Architecture of cannabinoid signaling in mouse retina

Shu-Jung Hu, Andy Arnold, Jacqueline M. Hutchens, Josh Radicke, Benjamin F. Cravatt, Jim Wager-Miller, Ken MacKie, Alex Straiker

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Cannabinoid receptors and their ligands constitute an endogenous signaling system that is found throughout the body, including the eye. This system can be activated by Δ9-tetrahydrocannabinol, a major drug of abuse. Cannabinoids offer considerable therapeutic potential in modulating ocular immune and inflammatory responses and in regulating intraocular pressure. The location of cannabinoid receptor 1 (cB1) in the retina is known, but recently a constellation of proteins has been identified that produce and break down endocannabinoids (eCBs) and modulate CB1 function. Localization of these proteins is critical to defining specific cannabinoid signaling circuitry in the retina. Here we show the localization of diacylglycerol lipase-α and -β (DGLα/β), implicated in the production of the eCB 2-arachidonoyl glycerol (2-AG); monoacylglycerol lipase (MGL) and α/β-hydrolase domain 6 (ABHD6), both implicated in the breakdown of 2-AG; cannabinoid receptor-interacting protein 1a (CRIP1a), a protein that may modulate CB1 function; and fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA), which have been shown to break down the eCB anandamide and related acyl amides. Our most prominent finding was that DGLα is present in postsynaptic type 1 OFF cone bipolar cells juxtaposed to CB1-containing cone photoreceptor terminals. CRIP1a is reliably presynaptic to DGLα, consistent with a possible role in cannabinoid signaling, and NAAA is restricted to retinal pigment epithelium, whereas DGLβ is limited to retinal blood vessels. These results taken together with previous anatomical and functional studies define specific cannabinoid circuitry likely to modulate eCB signaling at the first synapse of the retina as well as in the inner plexiform layer.

Original languageEnglish
Pages (from-to)3848-3866
Number of pages19
JournalJournal of Comparative Neurology
Volume518
Issue number18
DOIs
Publication statusPublished - 2010 Sep 15

Fingerprint

Cannabinoid Receptors
Cannabinoids
amidase
Retina
Receptor-Interacting Protein Serine-Threonine Kinases
Monoacylglycerol Lipases
Retinal Cone Photoreceptor Cells
Retinal Vessels
Endocannabinoids
Proteins
Acids
Dronabinol
Lipoprotein Lipase
Retinal Pigment Epithelium
Street Drugs
Hydrolases
Intraocular Pressure
Amides
Synapses
Ligands

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Hu, S-J., Arnold, A., Hutchens, J. M., Radicke, J., Cravatt, B. F., Wager-Miller, J., ... Straiker, A. (2010). Architecture of cannabinoid signaling in mouse retina. Journal of Comparative Neurology, 518(18), 3848-3866. https://doi.org/10.1002/cne.22429
Hu, Shu-Jung ; Arnold, Andy ; Hutchens, Jacqueline M. ; Radicke, Josh ; Cravatt, Benjamin F. ; Wager-Miller, Jim ; MacKie, Ken ; Straiker, Alex. / Architecture of cannabinoid signaling in mouse retina. In: Journal of Comparative Neurology. 2010 ; Vol. 518, No. 18. pp. 3848-3866.
@article{86e33bb336d44784a63d71b68127143f,
title = "Architecture of cannabinoid signaling in mouse retina",
abstract = "Cannabinoid receptors and their ligands constitute an endogenous signaling system that is found throughout the body, including the eye. This system can be activated by Δ9-tetrahydrocannabinol, a major drug of abuse. Cannabinoids offer considerable therapeutic potential in modulating ocular immune and inflammatory responses and in regulating intraocular pressure. The location of cannabinoid receptor 1 (cB1) in the retina is known, but recently a constellation of proteins has been identified that produce and break down endocannabinoids (eCBs) and modulate CB1 function. Localization of these proteins is critical to defining specific cannabinoid signaling circuitry in the retina. Here we show the localization of diacylglycerol lipase-α and -β (DGLα/β), implicated in the production of the eCB 2-arachidonoyl glycerol (2-AG); monoacylglycerol lipase (MGL) and α/β-hydrolase domain 6 (ABHD6), both implicated in the breakdown of 2-AG; cannabinoid receptor-interacting protein 1a (CRIP1a), a protein that may modulate CB1 function; and fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA), which have been shown to break down the eCB anandamide and related acyl amides. Our most prominent finding was that DGLα is present in postsynaptic type 1 OFF cone bipolar cells juxtaposed to CB1-containing cone photoreceptor terminals. CRIP1a is reliably presynaptic to DGLα, consistent with a possible role in cannabinoid signaling, and NAAA is restricted to retinal pigment epithelium, whereas DGLβ is limited to retinal blood vessels. These results taken together with previous anatomical and functional studies define specific cannabinoid circuitry likely to modulate eCB signaling at the first synapse of the retina as well as in the inner plexiform layer.",
author = "Shu-Jung Hu and Andy Arnold and Hutchens, {Jacqueline M.} and Josh Radicke and Cravatt, {Benjamin F.} and Jim Wager-Miller and Ken MacKie and Alex Straiker",
year = "2010",
month = "9",
day = "15",
doi = "10.1002/cne.22429",
language = "English",
volume = "518",
pages = "3848--3866",
journal = "Journal of Comparative Neurology",
issn = "0021-9967",
publisher = "Wiley-Liss Inc.",
number = "18",

}

Hu, S-J, Arnold, A, Hutchens, JM, Radicke, J, Cravatt, BF, Wager-Miller, J, MacKie, K & Straiker, A 2010, 'Architecture of cannabinoid signaling in mouse retina', Journal of Comparative Neurology, vol. 518, no. 18, pp. 3848-3866. https://doi.org/10.1002/cne.22429

Architecture of cannabinoid signaling in mouse retina. / Hu, Shu-Jung; Arnold, Andy; Hutchens, Jacqueline M.; Radicke, Josh; Cravatt, Benjamin F.; Wager-Miller, Jim; MacKie, Ken; Straiker, Alex.

In: Journal of Comparative Neurology, Vol. 518, No. 18, 15.09.2010, p. 3848-3866.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Architecture of cannabinoid signaling in mouse retina

AU - Hu, Shu-Jung

AU - Arnold, Andy

AU - Hutchens, Jacqueline M.

AU - Radicke, Josh

AU - Cravatt, Benjamin F.

AU - Wager-Miller, Jim

AU - MacKie, Ken

AU - Straiker, Alex

PY - 2010/9/15

Y1 - 2010/9/15

N2 - Cannabinoid receptors and their ligands constitute an endogenous signaling system that is found throughout the body, including the eye. This system can be activated by Δ9-tetrahydrocannabinol, a major drug of abuse. Cannabinoids offer considerable therapeutic potential in modulating ocular immune and inflammatory responses and in regulating intraocular pressure. The location of cannabinoid receptor 1 (cB1) in the retina is known, but recently a constellation of proteins has been identified that produce and break down endocannabinoids (eCBs) and modulate CB1 function. Localization of these proteins is critical to defining specific cannabinoid signaling circuitry in the retina. Here we show the localization of diacylglycerol lipase-α and -β (DGLα/β), implicated in the production of the eCB 2-arachidonoyl glycerol (2-AG); monoacylglycerol lipase (MGL) and α/β-hydrolase domain 6 (ABHD6), both implicated in the breakdown of 2-AG; cannabinoid receptor-interacting protein 1a (CRIP1a), a protein that may modulate CB1 function; and fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA), which have been shown to break down the eCB anandamide and related acyl amides. Our most prominent finding was that DGLα is present in postsynaptic type 1 OFF cone bipolar cells juxtaposed to CB1-containing cone photoreceptor terminals. CRIP1a is reliably presynaptic to DGLα, consistent with a possible role in cannabinoid signaling, and NAAA is restricted to retinal pigment epithelium, whereas DGLβ is limited to retinal blood vessels. These results taken together with previous anatomical and functional studies define specific cannabinoid circuitry likely to modulate eCB signaling at the first synapse of the retina as well as in the inner plexiform layer.

AB - Cannabinoid receptors and their ligands constitute an endogenous signaling system that is found throughout the body, including the eye. This system can be activated by Δ9-tetrahydrocannabinol, a major drug of abuse. Cannabinoids offer considerable therapeutic potential in modulating ocular immune and inflammatory responses and in regulating intraocular pressure. The location of cannabinoid receptor 1 (cB1) in the retina is known, but recently a constellation of proteins has been identified that produce and break down endocannabinoids (eCBs) and modulate CB1 function. Localization of these proteins is critical to defining specific cannabinoid signaling circuitry in the retina. Here we show the localization of diacylglycerol lipase-α and -β (DGLα/β), implicated in the production of the eCB 2-arachidonoyl glycerol (2-AG); monoacylglycerol lipase (MGL) and α/β-hydrolase domain 6 (ABHD6), both implicated in the breakdown of 2-AG; cannabinoid receptor-interacting protein 1a (CRIP1a), a protein that may modulate CB1 function; and fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA), which have been shown to break down the eCB anandamide and related acyl amides. Our most prominent finding was that DGLα is present in postsynaptic type 1 OFF cone bipolar cells juxtaposed to CB1-containing cone photoreceptor terminals. CRIP1a is reliably presynaptic to DGLα, consistent with a possible role in cannabinoid signaling, and NAAA is restricted to retinal pigment epithelium, whereas DGLβ is limited to retinal blood vessels. These results taken together with previous anatomical and functional studies define specific cannabinoid circuitry likely to modulate eCB signaling at the first synapse of the retina as well as in the inner plexiform layer.

UR - http://www.scopus.com/inward/record.url?scp=77955675828&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955675828&partnerID=8YFLogxK

U2 - 10.1002/cne.22429

DO - 10.1002/cne.22429

M3 - Article

C2 - 20653038

AN - SCOPUS:77955675828

VL - 518

SP - 3848

EP - 3866

JO - Journal of Comparative Neurology

JF - Journal of Comparative Neurology

SN - 0021-9967

IS - 18

ER -

Hu S-J, Arnold A, Hutchens JM, Radicke J, Cravatt BF, Wager-Miller J et al. Architecture of cannabinoid signaling in mouse retina. Journal of Comparative Neurology. 2010 Sep 15;518(18):3848-3866. https://doi.org/10.1002/cne.22429